Claudia Roth

Citigroup Global Markets, Inc. (Broker) (CGMI-Broker) is the broker/dealer division of Citigroup Global Markets, Inc., an investment bank headquartered in New York City with additional offices across the US. The firm was founded in 2004 and is a subsidiary of Citigroup Financial Products, Inc., ultimately held by Citigroup, Inc. (NYSE: C). CGMI-Broker covers all market capitalizations of the major global indices and provides macro and quantitative analysis of global markets and sector trends. Their core focus of the group is to help investing clients make informed decisions by providing value-added, independent, insightful analysis.

Chromatin, Inc. provides seed and feedstock products for traditional agriculture and bio-industrial processes. The firm markets seed products under its Sorghum Partners brand, primarily the grain sorghum and forage sorghum seed types. It also delivers sorghum products for companies seeking renewable feedstock. Its service areas encompass supplying seed, contracting growers, providing agronomic support, and overseeing harvest and delivery of feedstock in the form and specifications required by bio-processors. The company was founded by Kevin Keith, Daphne Preuss and Gregory Paul Copenhaver in 2001 and is headquartered in Chicago, IL.

Citigroup Global Markets Holdings, Inc. provides investment banking and securities brokerage services. It offers financial advisory, research and capital raising services to corporations, governments and individuals. The company was founded in 1977 and is headquartered in New York, NY.

Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC.

Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.

Gliknik, Inc. discovers and develops biotechnology drugs for autoimmune diseases and cancer. The company was founded by David S. Block and Scott E. Strome in 2007 and is headquartered in Baltimore, MD.

Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL.

Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA.

Toucan Capital Corp (Toucan Capital) is a private equity firm founded in 1997 by Linda F. Powers and Robert F. Hemphill. The firm is headquartered in Bethesda, Maryland.

Part of Corteva, Inc., Fibra Dupont Sudamerica SA produces textiles and synthetic fibers. The company is based in Americana, Brazil.

Artecola Industrias Quimicas Ltda. manufactures industrial adhesives and laminates. It supplies products to the footwear, wood, automotive, construction, textile, consumer products, paper, and packaging industries in Latin America. The company has production plants in Brazil, Mexico, Argentina, and Colombia, and distribution centers in Brazil, Chile, and Peru. The company was founded by Francisco Xavier Kunst in 1948 and is headquartered in Campo Bom, Brazil.

Renner Dupont Tintas Automotivas e Industriais SA is a Brazilian company that manufactures automotive and industrial paints. The private company is based in Guarulhos, Brazil.

Quaker Partners Management LP (Quaker Partners Mgmt) is a venture capital subsidiary of Independence Capital Partners Inc founded in 2002 by Ira Mark Lubert and Paul Sherrill Neff. The firm is headquartered in Philadelphia, Pennsylvania.

The Wistar Institute provides biomedical research services. It researches on diseases such as cancer, cardiovascular, autoimmune disorders and infectious diseases and develops vaccine. The company was founded in 1892 and is headquartered in Philadelphia, PA

Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL.

Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC.

Fenwal, Inc. is a global medical technology company focused on improving transfusion medicine through expertise in blood separation, collection, filtration, storage, and transfusion. It offers apheresis collections, manual collections, therapeutics, specialty products, platelet safety, data management, data management, and customer solutions The company was founded in 1949 and is headquartered in Lake Zurich, IL.

The American Chamber of Commerce (China) is a non-profit organization with a membership of 4,000 individuals from 900 companies operating across China. The organization's mission is to help American companies succeed in China through advocacy, information, networking, and business support services. With headquarters in Beijing, AmCham also serves central, southern, and northeast China through its chapters in Tianjin, Guangzhou, Shenyang, and Dalian. AmCham China has more than 30 working groups and holds over 150 events each year.

Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland.

CTI Clinical Trial & Consulting Services, Inc. engages in the provision o clinical trial and consulting services. It offers multi-specialty clinical research site that conducts phase I-IV trials. The firm focuses in therapeutic approach for pharmaceutical, biotechnology, and medical device firms with clinical and disease area expertise in rare diseases, regenerative medicine and gene therapy, immunology, transplantation, nephrology, hematology and oncology, neurology, infectious diseases, hematology, cardiopulmonary, and pediatric populations. The company was founded by Timothy J. Schroeder and Lynn Fallon in 1999 and is headquartered in Covington, KY.

Corridor Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. The company was founded on February 1, 2008 and is headquartered in Lutherville, MD

Part of Fresenius SE & Co. KGaA, Fresenius Kabi Pharmaceuticals Holding, Inc. is a pharmaceutical company based in Wilmington, DE. The company develops pharmaceutical products.

Part of Schouw & Co A/S, Dupont Cipatex SA is a Brazilian company that manufactures and supplies non-woven fabrics. The company is based in Cerquilho, Brazil. Dupont Cipatex was acquired by Fibertex Nonwovens A/S on February 05, 2018.

Baxter Ventures (Baxter Ventures) is a venture capital firm subsidiary of Baxter International, Inc. founded in 2011. The firm is headquartered in Deerfield, Illinois.

iBIO Institute is a biotechnology innovation organization that provides education programs. The private company is based in Chicago, IL.

Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands.

Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts.

MotorLeaf, Inc. provides hardware and software for growers. It offers Motorleaf hardware, a plug n' play solution that enables users to decide which part of grow operation user could control/monitor and automate; and Motorleaf Operating System, an accessible online or offline solution on wireless enabled device, such as desktop, laptop, tablet, and smartphone. The company was founded by Ramen Dutta, Ally Monk and Scott Dickson Dagondon in June 2015 and is headquartered in Montreal, Canada.

Summit Ag Investors LLC ( Summit Ag Investors) is a private equity/venture capital subsidiary of Summit Agricultural Group founded in 2010 by Bruce L. Rastetter. The firm is headquartered in Alden, Iowa.

Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA.

viTToria Biotherapeutics, Inc. is a gene-edited cell therapeutics company based in Philadelphia, PA. The company is developing novel CAR-T cell therapies using their proprietary Senza5 platform, which maximizes stemness, durability, and target cell cytotoxicity. The technology is exclusively licensed from the University of Pennsylvania and has pipeline applications in oncology and autoimmune diseases. The company was founded by Bruce A. Peacock and Nicholas Siciliano, with Nicholas Siciliano serving as CEO since incorporation.

Carbon Biosciences, Inc. is a biotech company that is based in Boston, MA. The company is focused on expanding the therapeutic potential of gene therapy through its proprietary platform which leverages novel parvoviruses that have been pressure tested by nature to target specific tissues and carry a larger cargo with minimal neutralizing immunity and the potential to re-dose. The company is working to expand the gene therapy toolbox for the treatment of the world's most devastating and difficult to treat diseases. Carbon was founded by Longwood Fund and gene therapy pioneers, John F. Engelhardt, Ph.D., and Robert M. Kotin, Ph.D.

Pathway To Cures (Pathway To Cures) is a venture capital firm founded in 2022. The firm is headquartered in New York.

True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA.